Refractory Achalasia: Is POEM Changing the Paradigm?

Patel, Dhyanesh A.; Vaezi, Michael F.

doi:10.1016/j.cgh.2017.04.032

Cited by 4 publications

(4 citation statements)

References 30 publications

(35 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are multitudes of knives, clips, injection solutions, electrosurgical units (ESUs), and suturing devices on the market today (Harlow et al, 2020). Even more recently, newer technologies have emerged, such as the Speedboat-RS2 (Creo Medical, Chepstow, United Kingdom), that attempt to decrease procedure time by creating an “all-in-one” tool that negates the exchange of several devices (Patil, Dalal, & Maydeo, 2020). For example, the Speedboat-RS2 (Creo Medical, Chepstow, United Kingdom) uses an integrated injection needle, bipolar electrodes, and microwave coagulation—making it able to complete the entire procedure with one instrument (Harlow et al, 2020) (Figure 5).…”

Section: Discussionmentioning

confidence: 99%

“…Currently, our team at Baylor St. Luke's Medical Center is comparing bipolar and monopolar current with POEM in a new trial. This technology is still being reviewed and explored as further studies are warranted (Patil et al, 2020).…”

Section: Discussionmentioning

confidence: 99%

“…However, POEM is indicated as the preferred treatment for Type III achalasia (Khashab et al, 2020). Distinguishing the subtype of achalasia present will facilitate choosing the optimal treatment modality (Patel, Lappas, & Vaezi, 2017).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Peroral Endoscopic Myotomy

Dawley¹

2023

Gastroenterology Nursing

View full text Add to dashboard Cite

a chalasia Presents as a Rare Disorder, affecting only 0.3-1.63 per 100,000 adults yearly, worldwide (Sadowski, ackah, Jiang, & Svenson, 2010). In the United States, it is estimated that 20,000-40,000 patients are affected by it, occurring equally amongst genders (Vaezi, Pandolfino, yadlapati, Greer, & Kavitt, 2020) with no racial correlation (Brindise, Khashab, & El abiad, 2021). Classic symptoms of achalasia include heartburn, dysphagia, regurgitation (Brindise et al., 2021), chest pain, and weight loss (Chadalavada, Thota, Raja, & Sanaka, 2020). achalasia is the leading indication for performance of peroral endoscopic myotomy to alleviate its symptoms, more frequently referred to by the acronym "POEM" (Chadalavada et al., 2020). POEMs are increasingly practiced worldwide since its original advent (Fajardo, Petrov, Bakhos, & abbas, 2020). Achalasia TypesThe Chicago classification divides achalasia into three subtypes (Pandolfino et al., 2008). achalasia Type I is characterized by aperistalsis with absence of panesophageal pressurization (Inoue et al., 2018), and it is the

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Peroral Endoscopic Myotomy

Dawley¹

2023

Gastroenterology Nursing

View full text Add to dashboard Cite

show abstract

“…Treatment options in all patients aim to reduce lower esophageal sphincter pressure and improve outflow. In pediatrics, there are no standardized protocols for optimal management, and even less so when recurrent or persistent symptoms after endoscopic or surgical therapy occur, a condition described as refractory achalasia (6) . Pharmacological therapies such as Clostridium botulinum toxin injection or calcium channel blockers are not recommended because of its short-term effectiveness and side effects (1) .…”

Section: Discussionmentioning

confidence: 99%

Peroral endoscopic myotomy in a pediatric patient with refractory achalasia: a case report and review of the literature

Calixto-Aguilar

Gonzales-Carazas

Calderón

et al. 2021

Rev Gastroenterol Peru

View full text Add to dashboard Cite

A 15-year-old male patient presented with dysphagia, regurgitation, weight loss and retrosternal pain. The diagnosis of achalasia was made 4 years before. The esophagogram revealed severe esophagus dilatation and the classic “bird-beak” termination. A Heller myotomy plus fundoplication and endoscopic balloon dilatation were conducted four months previously. Nevertheless, the symptoms persisted and the last high-resolution manometry study still showed achalasia type II. The patient underwent a peroral endoscopic esophageal myotomy (POEM). POEM is a feasible and safe procedure for experienced and properly- equipped health care delivery centers and could be used as a rescue treatment in refr e present the youngest patient with achalasia in our region who had a successful response to rescue POEM.

show abstract

Achalasia

Naik¹,

Patel²

2019

Evaluation and Management of Dysphagia

View full text Add to dashboard Cite

Refractory Achalasia: Is POEM Changing the Paradigm?

Cited by 4 publications

References 30 publications

Peroral Endoscopic Myotomy

Peroral Endoscopic Myotomy

Peroral endoscopic myotomy in a pediatric patient with refractory achalasia: a case report and review of the literature

Achalasia

Contact Info

Product

Resources

About